New Ocular Therapeutix Target Price Amid Support
The small-cap firm is likely to see defense by professional managers.
The small-cap firm is likely to see defense by professional managers.
Is this a positive or negative for Ondas? let’s discuss.
Plus, we’re buying more shares of these two names.
Here’s our trading plan for Friday and updates on key holdings.
Some strange but true updates on our “$10K Portfolio” names.
Short interest is growing in Ondas as it prepares for increased defense spending.
The Federal Reserve chair’s address hurt equities, including several of our names.
The Federal Reserve chair seems to understand an obvious truth about the economy.
The CIA director reportedly visited Russia to warn about attacks on NATO allies.
On a slow news day we’re looking to build onto these three small-cap positions.